Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
bioAffinity Technologies secures approximately $4 million in a registered direct financing and concurrent private placement under Nasdaq rules.
Amount Raised
$4 Million
Round Type
Seed
Jersey CityBiotechnologyHealth CareHealth DiagnosticsDescription
bioAffinity Technologies, Inc. has entered into a definitive agreement to sell shares of common stock and warrants to an institutional investor. The gross proceeds from the offering are expected to be approximately $4 million. The funds will be used for working capital and to support growing sales for its noninvasive test for lung cancer
Fundz sees it the moment bioAffinity Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
bioAffinity Technologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.